Un Audited Financial Result for First Quarter Ended on June 30, 2026.

Ami.Ar PROTEIN INDUSTRIES LTD. Date: 14.08.2026 FORMERLY ANKUR PROTEIN INDUSTRIES LTD. BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Fort, Mumbai-400 001. Company Code: 519471 Dear Sir/Madam, SUB: Outcome of Board Meeting dated 14th August 2026 In continuation of our communication dated 10rH August 2026 informing the date of Board Meeting. The Board of Directors of the Company as its meeting held on 14th August 2026, and the same meeting commenced at 03.30 p.m and concluded at~,.m. In that meeting the Board has decided following matters: 1. Considered and approved the Unaudited Financial Results of the Company for the Quarter ended on June 30, 2026 in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations, along with the Limited Review Report issued by Statutory Auditor. 2. Approved the Adoption of Draft Directors' Report for the financial year 2025-26 along with its Annexures and other reports to be included in the Annual Report 2025-26. 3. Considered and approved the notice of 3'3rd Annual General Meeting of the Members of the Company to be held on Wednesday so= September, 2026 at Registered Office of the Company situated at Sarkhej Bavla Highway, Opp Bhagyoday Hotel, Changodar, Ahmedabad- 382213. 4. Considered and approved the dates for Closure of Register of Members & Share Transfer Books (Book Closure) of the Company for the purpose of the Annual General Meeting from Wednesday 23/09/2026 to Wednesday 30/09/2026 (Both days inclusive). 5. The Company has availed e-voting services of the CDSL. The details of remote e-voting are given under: Sr. No Particulars Date and Time 1 Cut-off date for determining rights of entitlement of Tuesday, the 22nd September 2026 remote e-voting 2 Date and time of commencement of remote e-voting 9:00 A.M on Sunday, the 27th September, 2026 3 Date and time of commencement of remote e-voting 5:00 P.M on Tuesday, the 29th September, 2026 6. Consider and approved Related party Transactions with M/s. Ankur Oil industries related to Sale of Movable Tin Filing Machineries on Arm Length Basis subject to approval of Shareholders in upcoming AGM. 7. Consider and approved Commission paid to Non-Executive Directors subject to approval of Shareholders in upcoming AGM. 8. Consider and approved Revision in Remuneration of Managing Director and Whole Time Director · t to approval of Shareholders in upcoming AGM. FOR, AMBAR PROTEIN JNDUS:[1.IMRIIET EO \NDus~ .a:i1. ~ Kindly take the same on record and oblige a. AH~BAD Cf> Thanking you, · \ i nc OfficeP· \ ~ 1,- :'>.>\ ; Plot No. 351, 353, 358, Opp. Bhagyoday Hotel, Sarkhej - Bavla Highway, Cl:langodar, Ta. . ~ Cl Dist. : Ahmedabad -382213, Gujarat. I M. : 9879553424 E. : ambarprotein@gmail.com W. : www.ambarprotein.com GSTIN No.: 24AABCM0541N1ZM I PAN No.: AABCM0541N I CIN No.: L15400GJ1992PLC018758 Subject to Ahmadabad Jurisdiction Ami.Ar PROTEIN INDUSTRIES LTD. Date: 14.08.2026 FORMERLY ANKUR PROTEIN INDUSTRIES LTD. BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Fort, Mumbai-400 001. Company Code: 519471 Ref: Script Code: - 519471, Script ID: - AMBARPIL Dear Sir Sub: Submission of Unaudited Financial Results for the Quarter ended June 30, 2026 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In reference to the captioned subject and pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following, as approved by the Board of Directors at its meeting held on August 14, 2026: 1. Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2026; 2. Limited Review Report issued by the Statutory Auditors of the Company. Kindly take the same on your records Thanking you, FOR, AMBAR PROrEtN INDUSr,lE~LIMITE.D e,.,p~ffic '' Plot No. 351, 353, 358, Opp. Bhagyoday Hotel, Sarkhej - Bavla Highway, Changodar, Ta. : Sanad, Dist. : Ahmedabad -382213, Gujarat. I M. : 9879553424 E. : ambarprotein@gmail.com W. : www.ambarprotein.com GSTIN No.: 24AABCM0541 N1 ZM I PAN No.: AABCM0541 N I CIN No.: L 15400GJ1992PLC018758 Subject to Ahmedabad Jurisdiction F.enil P Shah and Associates F nil P. Shah Chartered Accountants FCA, ACMA, MIMA, GSTP JN DI A +91 98257 97514 tndependant Auditor's Limited Review Re_»ort Of! the Unaudited Standalone Quarterly Financial Results of the Ambar Protein Industries Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligatrons and orsclosure Requirements] Regulations, 2015 {as am~.n.ged) TO THE BOARD OF DIRECTORS OF AMBAR PROTEIN INDUSTRIES LIMITED We have reviewed the unaudited financial results of AMBAR PROTEIN INDUSTRIES J\IIITEP ( e 'Co ny') for the quarter ended June, 2026 (the 'Statement') attached herewith, being submitte the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure- · ~quirements) Regulations, 2015 (the 'Regulations'), as amended. This statement which is the responsibility of the Company's management arid has bee,n approved by the Board of Directors of the Company, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, "Interim Financial Report ng" (\ AS 4) prescribed under Section 133 of the Companies Act, 2013 read with R le 3 of Co panir;s (lndia1· Ace' unti ~ Standards) Rules, 2015 and the Circular. Our responsibility is to express a co , the Entity"', issued by the Institute of Chartered Accountantso f India. This stan ard requires that w · p!a and perform the review to obtain moderate assurance as to whether the Statements are free of mate(ar mtssts ement. A review .f interim financial information consists of making tte and applying analytical and other review be identified in an audit. Accordingly we do not express an audit opinion. Based on our review condilcte as a ave othi t e tion that causes us to believe that the accompanying State ent, prepared in cor ance 1 the re ognition and measurement principles laid down in the applicable Indian. Acco4 tin~.,Stancl~rds (' Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules-issued there under and other recognized accounting principles generally accepted in India has not discl ed the infQTmatlon required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and eguir mentsfRegulations, 2015, as amended, including the manner in which it is to be disclosed, or that it I misstatement. For, Fenil P. Shah and Associates Place : Ahmedabad Date : 14/08/2026 UDIN: 26141088BZDWAF5950 (CA Fenil P. Shah) M. No. 141088 \. +91 85119 10789 offlce@cofenil.in @» www.cefenll.ln , -;,;, -.,. :t-.r"""'- -·'I"· - 1 303, Yash Anent, Opp. Old RBI, Ashram Road, Ahmedabad - 380 009 Amb1r PROTEIN INDUSTRIES LTD. FORMERLY ANKUR PROTEIN INDUSTRIES LTD. UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED June 30, 2026 Amount in Lacs) 2uarter Ended Year Ended 30.06.2026 31.03.2026 30.06.2025 31.03.2026 Sr.No. Particulars Unaudited Audited Unauditea Audited 1 Income (a) Revenue from operations 11,344.84 14,679.97 11,727.19 50,065.59 (b) Other Income 18.97 21.87 19.13 78.12 lA Total Income 11,363.81 14,701.83 11,746.31 50,143.72 2 Expenses: (a) Cost of Material consumed 10,226.22 15,130.54 11,029.59 48,776.77 (b) Purchases stock -In- trade - 0.43 (1,168.40) (980.72) (c) Changes in Inventories Finished Goods, Work -in-progress and stock-in-trade 313.33 247.55 (d) Employee Benefits expenses 57.98 62.78 47.04 236.04 (e) Finance Cost 47.09 54.75 53.37 202.96 (f) Depreciation, amortization, impairment and obsolescence 36.24 35.50 33.30 136.74 (g) Other expenses 172.20 243.62 188.39 832.91 2A Total expenses 10,853.05 14,358.80 11,599.24 49,205.13 3 Profit /(loss) before exceptional items and tax (lA • 2A) 510.76 343.03 147.07 938.59 4 Exceptional item - - - - 5 Profit/ (loss) before tax (3·4) 510.76 343.03 147.07 938.59 6 Tax Expense a) [Showing first 8,000 characters — download PDF for full document]